NASDAQ:WVE - Wave Life Sciences Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $19.14
  • Forecasted Upside: 111.99 %
  • Number of Analysts: 7
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$9.03
▲ +0.4 (4.63%)
1 month | 3 months | 12 months
Get New Wave Life Sciences Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for WVE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for WVE

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$19.14
▲ +111.99% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Wave Life Sciences in the last 3 months. The average price target is $19.14, with a high forecast of $27.00 and a low forecast of $10.00. The average price target represents a 111.99% upside from the last price of $9.03.
Buy
The current consensus among 7 investment analysts is to buy stock in Wave Life Sciences. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/2/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
8/31/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/29/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
2/27/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/27/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
8/25/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
10/24/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
11/23/2020

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/20/2020MizuhoLower Price TargetBuy$21.00 ➝ $19.00Low
i
10/22/2020Royal Bank of CanadaInitiated CoverageSector Perform$13.00High
i
9/22/2020TruistBoost Price Target$20.00 ➝ $27.00Low
i
6/7/2020MizuhoReiterated RatingBuy$21.00High
i
Rating by Salim Syed at Mizuho
1/2/2020HC WainwrightLower Price TargetBuy$33.00 ➝ $20.00Low
i
Rating by Debjit Chattopadhyay at HC Wainwright
12/31/2019SunTrust BanksReiterated RatingBuy$20.00Medium
i
12/31/2019SVB LeerinkDowngradeOutperform ➝ Market Perform$33.00 ➝ $10.00High
i
Rating by M. Foroohar at SVB Leerink LLC
12/30/2019MizuhoInitiated CoverageBuy$65.00Low
i
Rating by Salim Syed at Mizuho
12/17/2019SunTrust BanksLower Price TargetBuy$39.00 ➝ $27.00High
i
12/17/2019GuggenheimLower Price TargetBuy$43.00 ➝ $25.00High
i
Rating by Whitney Ijem at Guggenheim
12/16/2019MizuhoInitiated CoverageBuy$65.00High
i
Rating by Salim Syed at Mizuho
12/16/2019CowenReiterated RatingHoldHigh
i
Rating by Yaron Werber at Cowen Inc
11/21/2019MizuhoInitiated CoverageBuy$65.00Medium
i
Rating by Salim Syed at Mizuho
11/1/2019GuggenheimInitiated CoverageBuy$43.00High
i
10/9/2019HC WainwrightSet Price TargetBuy$33.00Low
i
Rating by Debjit Chattopadhyay at HC Wainwright
9/25/2019MizuhoReiterated RatingBuyLow
i
Rating by Salim Syed at Mizuho
7/31/2019HC WainwrightReiterated RatingBuyHigh
i
Rating by Debjit Chattopadhyay at HC Wainwright
7/30/2019CowenReiterated RatingHoldHigh
i
Rating by Yaron Werber at Cowen Inc
7/22/2019MizuhoReiterated RatingBuy$65.00High
i
Rating by Salim Syed at Mizuho
7/15/2019CowenInitiated CoverageMarket Perform ➝ Market PerformMedium
i
6/29/2019MizuhoSet Price TargetBuy$65.00High
i
Rating by Salim Syed at Mizuho
6/28/2019HC WainwrightSet Price TargetBuy$33.00High
i
Rating by Debjit Chattopadhyay at HC Wainwright
5/20/2019SunTrust BanksLower Price TargetBuy$39.00High
i
5/13/2019HC WainwrightReiterated RatingBuy$33.00Medium
i
Rating by Debjit Chattopadhyay at HC Wainwright
4/17/2019HC WainwrightReiterated RatingBuy ➝ Buy$49.00 ➝ $33.00High
i
Rating by Debjit Chattopadhyay at HC Wainwright
4/16/2019Stifel NicolausDowngradeBuy ➝ HoldHigh
i
4/15/2019MizuhoReiterated RatingBuy$65.00Low
i
Rating by Salim Syed at Mizuho
12/10/2018HC WainwrightSet Price TargetBuy$49.00Medium
i
Rating by Debjit Chattopadhyay at HC Wainwright
12/6/2018MizuhoSet Price TargetBuy$65.00Medium
i
Rating by Salim Syed at Mizuho
11/27/2018SVB LeerinkInitiated CoverageOutperform$61.00High
i
Rating by J. Sullivan at SVB Leerink LLC
11/12/2018HC WainwrightSet Price TargetBuy$49.00High
i
Rating by Debjit Chattopadhyay at HC Wainwright
11/11/2018SVB LeerinkReiterated RatingOutperformMedium
i
Rating by J. Sullivan at SVB Leerink LLC
8/10/2018HC WainwrightSet Price TargetBuy$49.00High
i
Rating by Debjit Chattopadhyay at HC Wainwright
8/9/2018MizuhoSet Price TargetBuy$65.00Medium
i
Rating by Salim Syed at Mizuho
8/6/2018Stifel NicolausInitiated CoverageBuy$56.00Low
i
7/23/2018HC WainwrightReiterated RatingBuy$49.00Low
i
Rating by D. Chattopadhyay at HC Wainwright
6/29/2018MizuhoSet Price TargetBuy$65.00High
i
Rating by Salim Syed at Mizuho
3/19/2018MizuhoBoost Price TargetBuy ➝ Buy$34.00 ➝ $65.00High
i
Rating by Salim Syed at Mizuho
3/13/2018SVB LeerinkLower Price TargetOutperform ➝ Outperform$64.00 ➝ $62.00High
i
Rating by G. Porges at SVB Leerink LLC
3/9/2018SunTrust BanksBoost Price TargetBuy$60.00Low
i
3/4/2018SVB LeerinkReiterated RatingOutperformHigh
i
Rating by G. Porges at SVB Leerink LLC
2/21/2018SVB LeerinkBoost Price TargetOutperform ➝ Outperform$53.00 ➝ $64.00Medium
i
2/20/2018MizuhoSet Price TargetBuy$34.00Medium
i
11/15/2017SVB LeerinkReiterated RatingOutperform$42.00 ➝ $53.00N/A
i
10/21/2017MizuhoSet Price TargetBuy$34.00N/A
i
8/18/2017MizuhoSet Price TargetBuy$34.00Low
i
8/10/2017Jefferies Financial GroupReiterated RatingBuy$42.00 ➝ $40.00Low
i
6/9/2017JMP SecuritiesReiterated RatingOutperform$40.00Low
i
6/8/2017Jefferies Financial GroupSet Price TargetBuy$42.00Low
i
4/26/2017Jefferies Financial GroupReiterated RatingBuy$42.00Medium
i
3/27/2017HC WainwrightReiterated RatingBuyHigh
i
Rating by C. Werther at HC Wainwright
2/15/2017HC WainwrightInitiated CoverageBuy$41.00N/A
i
Rating by C. Werther at HC Wainwright
12/13/2016Jefferies Financial GroupSet Price TargetBuy$42.00N/A
i
11/14/2016Jefferies Financial GroupBoost Price TargetBuy$28.00 ➝ $42.00N/A
i
11/10/2016JMP SecuritiesReiterated RatingBuyN/A
i
11/10/2016SVB LeerinkReiterated RatingOutperform$45.00N/A
i
Rating by P. Matteis at SVB Leerink LLC
8/16/2016SVB LeerinkReiterated RatingOutperform$20.00 ➝ $28.00N/A
i
8/16/2016JMP SecuritiesReiterated RatingBuyN/A
i
8/15/2016Jefferies Financial GroupSet Price TargetBuy$28.00N/A
i
5/17/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
Rating by Eun Yang at Jefferies Financial Group Inc.
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$52.00 ➝ $40.00N/A
i
Rating by Michael King at JMP Securities
12/7/2015SVB LeerinkReiterated RatingOutperformN/A
i
Rating by M. Schmidt at SVB Leerink LLC
12/7/2015SVB LeerinkInitiated CoverageOutperform$20.00N/A
i
12/7/2015SunTrust BanksInitiated CoverageBuy$26.00N/A
i
12/7/2015Jefferies Financial GroupInitiated CoverageBuy$28.00N/A
i
12/7/2015JMP SecuritiesInitiated CoverageOutperform$52.00N/A
i
(Data available from 11/23/2015 forward)
Wave Life Sciences logo
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. It focuses on programs in neurology in the central nervous system and neuromuscular system. The company has a research, license, and option agreement with Pfizer Inc. and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of stereopure oligonucleotide therapeutics and oligonucleotide therapeutics; and research, development, and develop antisense oligonucleotides. Wave Life Sciences Ltd. was founded in 2012 and is based in Singapore.
Read More

Today's Range

Now: $9.03
$8.63
$9.25

50 Day Range

MA: $8.07
$6.99
$9.14

52 Week Range

Now: $9.03
$6.61
$39.98

Volume

662,152 shs

Average Volume

773,727 shs

Market Capitalization

$440.47 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.35